Caldwell & Orkin’s Nucor NUE Stock Holding History

Caldwell & Orkin’s Portfolio NUE Stock Details NUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-50,420	Closed	-$3.01M	–	78
2017 Q1	$3.01M	Buy	+50,420	New	+$3.08M	1.68%	16
2015 Q3	–	Sell	-12,700	Closed	-$560K	–	86
2015 Q2	$560K	Buy	+12,700	New	+$610K	0.33%	64

Other funds holding NUE

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Caldwell & Orkin's NUE Position: Q2 2017 in Review

Caldwell & Orkin sold out of Nucor (NUE) in Q2 2017, closing a stake of 50,420 shares — an estimated $3.01M sold.

Caldwell & Orkin first reported a position in NUE in Q2 2015 and held it in 2 quarters. The position peaked at $3.01M in Q1 2017. 732 funds tracked by Wall St. Rank hold NUE as of Q2 2017.

Caldwell & Orkin reported no remaining Nucor position as of Q2 2017 after selling out during the quarter.
Caldwell & Orkin sold 50,420 Nucor shares in Q2 2017, an estimated $3.01M.
Caldwell & Orkin first reported a position in Nucor in Q2 2015 and held it in 2 quarters.
Caldwell & Orkin's Nucor position peaked at $3.01M in Q1 2017.
732 funds tracked by Wall St. Rank held Nucor as of Q2 2017.

Based on Caldwell & Orkin's 13F filing for Q2 2017, filed 10 Aug 2017.